Ernexa Therapeutics Selected for Emerging Track at 2026 Cell & Gene Meeting on the Mesa, Highlighting ERNA-101 and Focused Oncology Strategy
Ernexa selected for the Emerging Track, recognizing the Company among emerging innovators in the cell and gene therapy sectorPresident & CEO Sanjeev Luther to deliver an Innovation Spotlight presentation on October 6, 2026, at 1:30 PMPresentation to highlight Ernexa’s focused oncology strategy, beg…